Humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells for relapsed/refractory pediatric acute lymphoblastic leukemia.
Wang S, Wang X, Ye C, Cheng H, Shi M, Chen W, Qi K, Wang G, Wu Q, Zeng L, Li Z, Jing G, Zheng J, Xu K, Cao J.
Wang S, et al. Among authors: wang x, wang g.
Am J Hematol. 2021 May 1;96(5):E162-E165. doi: 10.1002/ajh.26123. Epub 2021 Feb 21.
Am J Hematol. 2021.
PMID: 33580974
Free article.
Clinical Trial.
No abstract available.